Obagi's enterprise value increased as Valeant offered a higher share value price of US$24 per share.

Dish Network would offer senior notes amounting to US$2.3 billion, double its previous announcement.

AstraZeneca purchases AlphaCore and its up and coming cholesterol drugs. AstraZeneca purchased through private placement US biotech company AlphaCore Pharma.

British Petroleum, in the wake of the 2010 oil spill liabilities, is selling off its wind farm operations in the US reportedly at US$1.5 billion.

HighMark Funds, the mutual fund arm of UnionBanCal is being sold to Nationwide Financial and Reich & Tang.

Cammeby's International Group would be purchasing the Monterey for the sum of US$250 million. One of the largest apartment towers in Manhattan would be purchased by Rubin Schron, Related Cos is selling one of its assets to the part owner of the Woolworth Building.

Optimer Pharmaceuticals is subject to many possible offers from other drug companies. The antibiotics pharmaceutical maker Optimer Pharmaceuticals Inc has been the subject of interest from GlaxoSmithKline Plc and Astellas Pharma Inc of Japan.

The Bronx Parking Development Corp skipped payment of interest to its bondholders and is now contemplating bankruptcy protection.

In a Financial Times report, AT&T and Verizon are said to be joining forces to make a bid for Vodafone shares in Verizon Wireless.

The MAS capital infusion of US$20 million would result in the merger of Attune Consulting and Sabre Technologies.